# Anti-Migraine Agents, Acute

## Length of Authorizations

180 Days

## Prior Authorization Criteria

- Is there any reason the patient cannot be changed to a medication not requiring prior approval?

  Acceptable reasons include:

  - Allergy to preferred medications
  - Contraindication to all preferred medications
  - History of unacceptable/toxic side effects to at least two preferred medications

## Additional Criteria

### Step Therapy

Step Therapy Approval Criteria

- For a drug requiring step therapy, there must have been inadequate clinical response to preferred alternatives, including a trial of at least 14 days with at least two medications not requiring prior approval
- For a non-preferred drug, there must have been inadequate clinical response to preferred alternatives, including a trial of at least 14 days with at least one medication requiring step therapy

Nurtec ODT quantity limit is 8 per 30 days

## Formulary

Central Nervous System (CNS) Agents: Anti-Migraine Agents, Acute

### Preferred

| Preferred     |                                        Generic Name |   Quantity Restrictions   | Time (Days) |
| :------------ | --------------------------------------------------: | :-----------------------: | :---------: |
| Naratriptan   |                 Naratriptan HCI Tab (all strengths) |             9             |     30      |
| Nurtec ODT ST |                      Rimegepant ODT (all strengths) | Determined pursuant to PA |             |
| Rizatriptan   | Rizatriptan Benzoate (all strengths & formulations) |             9             |     30      |
| Sumatriptan   |           Sumatriptan Succinate Tab (all strengths) |             9             |     30      |

### Non-Preferred

| Non-Preferred        |                                       Generic Name |   Quantity Restrictions   | Time (Days) |
| :------------------- | -------------------------------------------------: | :-----------------------: | :---------: |
| Almotriptan          |                                                    |                           |             |
| Dihydroergotamine    |                                                    |                           |             |
| Eletriptan           |                                                    |                           |             |
| Ergomar              |                                                    |                           |             |
| Frovatriptan         |                                                    |                           |             |
| Migergot             |                                                    |                           |             |
| Onzetra Xsail        | Sumatriptan Succinate Nasal Powder (all strengths) | Determined pursuant to PA |             |
| Reyvow               |                                                    |                           |             |
| Sumatriptan/Naproxen |                                                    |                           |             |
| Tosymra              |  Sumatriptan Succinate Nasal Spray (all strengths) | Determined pursuant to PA |             |
| Trudhesa             |                                                    |                           |             |
| Ubrelvy              |                                                    |                           |             |
| Zolmitriptan         |                                                    |                           |             |

## Links

[Criteria]https://pharmacy.medicaid.ohio.gov/sites/default/files/20221001_UPDL_Criteria_APPROVED.pdf#page=23)

[Preferred Drug List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20221001_UPDL_APPROVED_.pdf#page=13)